Company
Jade Biosciences, Inc. (JBIO)
Standardized SEC financial data for Jade Biosciences, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001798749 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-38.3%
Free cash flow
-$94.9M
Current ratio
21.09×
EPS (diluted)
$-3.19
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 |
|---|---|---|---|---|---|
| R&D expense | $7.9M | $15.0M | $38.6M | $64.2M | $93.1M |
| SG&A expense | $949K | $8.0M |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $167.4M | $129.2M | $122.4M | — | $78.6M | $88.4M |
| Total current assets |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$27.4M | -$39.1M | -$56.8M | — | — | -$94.7M |
| Capital expenditures |
Get JBIO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/JBIO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/JBIO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"